How serious is FDA warning about revolutionary blood-cancer

Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.

FDA warns of rare secondary cancer risk with CAR-T therapies

FDA investigates CAR-T therapy as causing cancer in rare cases

LLS Investment Pays Off: FDA Approves Immunotherapy for Blood Cancer Patients

Lyfgenia and Casgevy Become First FDA-Approved Gene Therapies for Sickle Cell Disease - Xtalks

ICancer Event

News and Opinions - World Stem Cell Summit

When a Revolutionary Cancer Treatment Causes Cancer

Myeloma News - Oncology/Hematology

Car-T Therapy May Increase Risk of Certain Cancers

Carvykti CAR-T gets warning label - STAT

CAR-T cell therapy: current limitations and potential strategies

Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs

James Wang, PhD on LinkedIn: More CAR-T Cell Therapies Will 'Ease Out the Shortage

FDA Issues Warning of Cancer Risk Linked to CAR-T Therapies